{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nTurkalj S. et al, (2023), Cell Stem Cell, 30, 722 - 740.e11
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLachowiez CA. et al, (2023), Blood Cancer Discov
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSallman DA. et al, (2023), J Clin Oncol
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium None., (2023), Nature, 614
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver NG. et al, (2023), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 23, S313 - S314
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver NG. et al, (2023), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 23, S312 - S312
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nJohnson L. et al, (2023), CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 23, S362 - S362
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJiao W. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nShuai S. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBhandari V. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSieverling L. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nZhang Y. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nCmero M. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nReyna MA. et al, (2022), Nature Communications, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDaver NG. et al, (2022), Cancer Discovery, OF1 - OF14
\n \n \n \n\n
\n \n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2022), AMERICAN JOURNAL OF HEMATOLOGY, 97, S5 - S5
\n \n \n \n\n \n
\n \n \n\n \n Conference paper\n \n
\n \n\n \n \n \nDaver N. et al, (2022), AMERICAN JOURNAL OF HEMATOLOGY, 97, S5 - S6
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDaver N. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S231 - S232
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nLachowiez C. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22, S240 - S241
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nVyas P. et al, (2022), Clinical Lymphoma, Myeloma and Leukemia, 22
\n \n \n \n\n
\n \n \n \n